- Research article
- Open Access
- Open Peer Review
Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study
BMC Health Services Research volume 19, Article number: 422 (2019)
Medication non-adherence is a major contributor to poor outcomes in diabetes. Previous research has shown an association between use of mail order pharmacy delivery and better medication adherence, but little is known about the barriers and facilitators to mail order pharmacy use in diabetes patients. This qualitative study examined factors related to mail order pharmacy use versus traditional “brick and mortar” pharmacies to refill prescriptions.
We conducted four 90-min focus groups in 2016 among 28 diabetes patients in the Hawaii and Northern California regions of Kaiser Permanente, a large integrated health care delivery system. We queried participants on their preferred mode for refilling prescriptions and perceived barriers and facilitators of mail order pharmacy use. One researcher independently coded each focus group transcript, with two of these transcripts double-coded by a second researcher to promote reliability. We employed thematic analysis guided by the Capability, Opportunity, Motivation, and Behavior (COM-B) framework using NVivo 11 software.
A total of 28 diabetes patients participated. Participants’ average age was 64.1 years; 57% were female; and racial/ethnic backgrounds included Asian/Native Hawaiian/Pacific Islander (36%), Black/African-American (21%) Hispanic/Latino (7%), and non-Hispanic White (36%). Analysis uncovered 26 themes related to the decision to use mail order pharmacy, with each theme representing a barrier or facilitator mapped to the COM-B framework. Most themes (20/26) fell into the COM-B category of ‘Opportunity.’ Opportunity barriers to mail order pharmacy use included unpredictability of medication delivery date, concerns about mail security, and difficulty coordinating refill orders for multiple prescriptions. In contrast, facilitators included greater access and convenience (e.g., no need to wait in line or arrange transportation) compared to traditional pharmacies. Motivational facilitators to mail order pharmacy use included receiving a pharmacy benefit plan incentive of a free one-month supply of prescriptions.
This study found that while patients with diabetes may benefit from mail order pharmacy use, they perceive numerous barriers to using the service. These findings will inform the design of interventions and quality improvement initiatives to increase mail order pharmacy use, which in turn may improve medication adherence and outcomes in diabetes patients, across health care systems.
Over 30 million Americans have type 2 diabetes , a condition associated with significant mortality and morbidity. Diabetes is currently the seventh leading cause of death in the United States , and the number of adults with the disease has gone up dramatically in the past two decades .
Good medication adherence is associated with improved health outcomes, fewer hospitalizations, and lower mortality in patients with diabetes [4,5,6]. However, only 50–70% of patients with chronic conditions are adherent to their regular medications [7,8,9]. Numerous studies have shown significant disparities in medication adherence among diabetes patients; minorities and low socioeconomic status (SES) patients with diabetes have poorer adherence to cardiometabolic medications shown to reduce diabetes complications [10,11,12,13,14,15].
Use of mail order pharmacy services to deliver medications, or mail order pharmacy use, accounts for at least an estimated 25% of pharmacy sales in the US, and rates are even higher among Americans ages 65 and up . Growth in mail order pharmacy services for outpatient prescription drugs has increased significantly since the 1980s; prior to this time, community-based pharmacies only occasionally offered ad hoc home delivery of medications to small, selected groups of patients based on factors such as patient home address and mobility . A growing body of research suggests that mail order pharmacy use is correlated with better medication adherence in diabetes [17,18,19,20,21] and across a wide range of chronic conditions [21,22,23,24,25,26]. Mail order pharmacy use is also associated with better health care outcomes and decreased health care utilization and costs [18, 23, 27,28,29]. Patients who use mail order pharmacy are more likely to be non-Hispanic White and have higher SES [17, 28]. Encouraging mail order pharmacy use in diverse populations may be an important tool for reducing disparities in health care outcomes .
Despite the evidence that mail order pharmacy may be an important strategy for improving diabetes care and outcomes, there is little to no published evidence identifying factors that influence patients’ uptake of this service. This qualitative study sought to identify and describe facilitators and barriers to mail order pharmacy use among diverse diabetes patients across two health systems. The purpose of this study was to inform patient outreach strategies for a pragmatic clinical trial designed to increase mail order pharmacy use among diabetes patients (clinical trial.gov registration number NCT02621476).
This study is set within two health care delivery systems that represent significant geographic, demographic, and structural diversity. Kaiser Permanente Northern California (KPNC) is a non-profit, integrated, group-model health care delivery system that in 2016 served close to 4 million members in a 13-county area of Northern California. This population is more than 30% non-white, 20% have attained a high school or lower level of education, and almost 50% have a household income <$50 K annually. Kaiser Permanente Hawaii (KPHI) is a non-profit, mixed model health maintenance organization that in 2016 served nearly 230,000 members throughout Hawaii. This population is 70% non-white, representing one of the most ethnically and racially diverse populations in the United States; 16% have attained a high school or lower level of education, and about 45% have a household income <$50 K annually. The patient membership of both health systems is representative of the demographic characteristics of the geographic areas the health systems serve.
Mail order pharmacy use at Kaiser Permanente (KP)
KPNC and KPHI have over 120 local “brick and mortar” pharmacies, located on-site within outpatient clinics and hospital facilities. KPNC and KPHI both maintain KP-run mail-order pharmacy distribution systems in coordination with the local KP pharmacies. Although most new prescriptions are filled in the local KP pharmacy, KP patients can elect to receive their prescription refills sent via mail order pharmacy, ordered either through the online patient portal (kp.org) or a toll-free pharmacy refill telephone service. KP patients have telephone access to a pharmacist to answer any medication-related questions one-on-one regardless of whether a refill was dispensed via mail order pharmacy or a local KP pharmacy. There is no minimum days’ supply required for mail order delivery. KP typically dispenses 90–100 day medication supplies for most oral diabetes prescriptions through both mail order and local KP pharmacies. Some patients have a financial incentive to use mail order pharmacy through their health insurance pharmacy benefit structure. This is typically receiving 3 copayments’ worth of medication for the price of 2 copayments (e.g., 3 months’ supply for the price of 2 months’ supply) when the medications are refilled by mail.
Potential participants were identified using KPNC and KPHI electronic health record data. Patients were considered eligible if they had one primary inpatient diagnosis or 2 outpatient diagnoses of type 2 diabetes (ICD9 codes 250.xx, 357.2, 362.0x, 366.41), were adults ages 18–89, and had filled an oral diabetes medication prescription (alpha-glucosidase inhibitor, amylin analog, biguanide, glucagon-like peptide-1 (GLP-1) receptor agonist, meglitinide, sodium-glucose cotransporter-2 (SGL2) inhibitor, sulfonylurea, thiazolidinedione (TZD)) between 7/1/2014 and 6/30/2015. Insulin users who had filled one of these oral diabetes medication prescriptions were included; insulin-only users were excluded. Since the study was conducted in English, non-English speakers were excluded. To identify influences on the use of both mail order and local pharmacies, we sought the perspectives of both current mail order pharmacy users and non-users. We defined mail order pharmacy users as those who had used the mail order pharmacy at least once during the 12-month period prior to recruitment using KP prescription refill databases; the 12-month window was used to reduce recall bias when patients conveyed their experiences with the service.
Study design and implementation
Patients were recruited via mailed letter and telephone outreach and offered $50 as an incentive for participation. We invited patients to participate in one of four 90-min focus groups in February and March of 2016, in either Oakland, CA (KPNC) or Honolulu, HI (KPHI). We used a 2 (site: KPNC vs. KPHI) × 2 (mail order pharmacy user vs. non-user) design to examine patient perspectives across health systems and across levels of familiarity with mail order pharmacy. We selected focus group methodology to elicit a broad range of unique ideas (rather than promote consensus) and to identify concepts that may inform future interventions promoting uptake of mail order pharmacy services. Participants provided written informed consent.
The research team included professionals from health services, public health, epidemiology, medicine, behavioral science, pharmacy, clinical administration, and project management backgrounds. This purposefully interdisciplinary team fostered our ability to identify a range of potential influences on mail order pharmacy use. Focus groups were conducted by three trained facilitators, one in KPNC and two in KPHI. The researchers, including interviewers, were unknown to research participants prior to data collection. To improve neutrality and consistency of responses across groups , we used standardized semi-structured interview guides using the same predetermined open-ended questions and moderator prompts . Interview questions queried participants about their pharmacy use preferences and the perceived benefits and disadvantages of both mail order and local pharmacies (please see the Additional file 1). Focus groups were digitally recorded, professionally transcribed verbatim, and deidentified prior to analysis. To augment qualitative data and describe the sample, we extracted demographic and clinical data from electronic health records. The study was approved by the KPNC Institutional Review Board; KPHI ceded Institutional Review Board (IRB) oversight for this study to KPNC. A completed ‘Standards for Reporting Qualitative Research’ checklist is included as supplemental material for reference.
Qualitative data analysis
We employed thematic analysis  to inductively and deductively derive themes from qualitative data  using NVivo 11 software (QSR Intl Pty Ltd.; Doncaster, Australia). We used the “Capability, Opportunity, Motivation, and Behavior” model (COM-B)  and closely related, validated Theoretical Domains Framework (TDF) [35, 36] to guide our qualitative analyses. These frameworks synthesize leading theories of behavior change, providing a systematic method for identifying influences on a given behavior. One doctoral candidate and two doctoral-level researchers in the fields of public health and behavioral medicine reviewed all transcripts to develop a coding scheme of broad meaningful themes. Guided by the COM-B framework, we focused on themes relevant to patients’ barriers and facilitators enacting two target behaviors: using mail order pharmacy and using a local pharmacy. We further defined each target behavior as encompassing three individual actions: requesting a prescription refill (e.g., in-person, by phone, or online), paying for a prescription refill (e.g., using a credit card online), and receiving a prescription refill (e.g., refilling it in-person from a pharmacist or receiving it in the mail). One researcher independently coded each focus group transcript, with two of these transcripts double-coded by a second researcher to promote reliability. Following the coding process, themes were mapped to COM-B categories : psychological capability (e.g., knowledge of the mail order pharmacy service); physical opportunity (e.g., the pharmacy location); social opportunity (e.g., the opportunity to interact with a pharmacist); automatic motivation (e.g., emotional reactions, rewards); and reflective motivation (e.g., conscious beliefs and intentions). The research team discussed the text allocated to each theme, and the themes allocated to each category, with discrepancies resolved by consensus.
Table 1 shows the demographic characteristics of study participants (n = 28). Slightly more than half were female (57%); the average age of participants was 64.1 years. Thirty-six percent of patients were Asian, Native Hawaiian or other Pacific Islander; 21% were Black/African-American; 7% were Hispanic/Latino, and 36% were non-Hispanic White.
Table 2 shows the 26 qualitative themes that emerged from the analysis, mapped to COM-B categories and stratified by perceived barriers vs. facilitators of using mail order pharmacy. As shown in Fig. 1, which displays the broad grouping of themes by COM-B category, most themes (20/26) fell into the category of ‘Opportunity.’ Of those, 13 themes (65%) represented barriers. These ‘opportunity’ barriers included unpredictability of the medication delivery date, concerns about mail security, and difficulty coordinating refill orders for multiple prescriptions. Patients’ quotes related to this theme appear in italics; the focus group type (mail order user versus (vs.) non-user), site, and participant number from which they emerge follow in parentheses:
You don’t know when you going to get it. They cannot give you a delivery date. […] I can’t do it, because I’m too scared about that, […] it cost me too much, too expensive to take that chance with insulin [of failing to receive it on time]. (Non-user) KPNC, 6.
So there’s a little apprehension on my part, because right now I currently live in a business district [where] the mail gets tampered with. (Non-user) KPHI, 2.
And then, if your mailbox is not in a safe place – because there’s been mail theft – you could lose your drugs through mail theft. And if you paid for the drug, I don’t know that they’re going to, you know, replenish it even though it was stolen and even though you paid for it. So those are the drawbacks. (User) KPHI, 6.
I have eight prescriptions, and because of the change of the medicines here and there, they’ve gotten all out of sync. So, I’m ordering eight different times in a three-month period, and that means I have to process eight different claims with the insurance company to be reimbursed for them. (User) KPNC, 1.
In contrast, ‘opportunity’ facilitators included greater access and convenience (e.g., no need to wait in line or arrange transportation) compared to traditional pharmacies, and finding the mail order pharmacy system easy to use. For example:
What’s good is that, once you’ve put in all your information, you can just sort of hit the, you know, the basic control [to automate the process]. So, like, your credit card, you don’t have to put in numbers each time. (User) KPHI, 2.
Kaiser’s website is very well organized and put together, and it’s a breeze, really. (User) KPHI, 8.
Social opportunity factors—specifically, the ability to avoid interactions with pharmacy staff— emerged as a facilitator of mail order pharmacy use:
Which is why I would rather use the mail-order service, because then you don’t have to deal with these overworked clerks. (User) KPHI, 7.
Others described positive interactions with pharmacy staff, and therefore viewed lack of interaction as a barrier to using mail order pharmacy:
I have gone into the pharmacy, and they’ve, like, just recently, they gave me a prescription…and I look at it when I get it – it was different. Okay? Now, this particular time, I was able to ask about it, and they said, “Oh, they changed manufacturers, and it’s the same medication.” But a couple of years ago, they had actually given me the wrong one. And if that happened with a mail order, and it’s something that I needed, you couldn’t, like, right then fix it. (Non-user) KPNC,5.
Within the ‘motivation’ category, barriers to using mail order pharmacy included worry that prescriptions, including diabetes-specific medications such as insulin, would be negatively impacted (e.g., “go bad”) if left outside upon delivery:
So I was kind of concerned about that, if it sat in the mailbox too long. Is it really effective, or is it ineffective? (User) KPHI, 10.
Also, I don’t know how good it would be for insulin to be shipped, because I don’t know how long it might sit in my mailbox before I get to it…. because it’s supposed to be kept cool…. And if it’s sitting in this tin mailbox in the beating sun… – (Non-user) KPNC, 5.
In contrast, facilitators included confidence in one’s ability to use the mail order pharmacy ordering system and receiving an incentive of a free one-month supply of medication each time a 3-month prescription was ordered:
Well, previously, when you had the mail order, I did participate. And, at that time, they offered, if you ordered 90 days, you’d get 30 days free. I liked that benefit. (Non-user) KPHI,2.
Further probing for the above patient confirmed that they had used mail order pharmacy more than 12 months ago but were non-users during the 12 month look back window, and that repeated address and PO box changes had discouraged them from using the service more recently.
…if they just going to approximate the way you’re going to save money from parking or a bus or whatever, things like that, it does – for me, it’s not enough marketing to convince me….But if it’s real savings, like it’s a lower cost to me, then I might look at it. (Non-user) KPNC, 16.
“I think the best reason that nobody has mentioned [within the focus group] yet is that you get the third month free. And it’s a tremendous savings.” (User)KPHI,2.
I started mail order for the free month. And when I started, I was taking only two medications. Now I take six, so if you listed how much savings, that, you know, it would be in the hundreds of dollars that getting that extra, you know, month for each medication. You know, because I’m a type 2 diabetic. I’m a heart patient. You know, so I take six medications a day. So the savings for me is tremendous, you know? That’s why I do mail order. And now, online, it’s so easy, you know? It’s so easy that I can’t see another way to do it, you know, because it would cost, you know, like I said, a couple hundred dollars at least. (User) KPHI, 12.
Finally, within the ‘capability’ category, barriers included lack of knowledge about how mail order pharmacy works (e.g., the processes of ordering and delivery) and lack of technological literacy:
If you need that certain medication that you have to go down and sign for it, how are you going to get that through the mail? [...] there’s some that they say is like a [controlled] substance, like, pain and stuff like that. To refill that, you have to go down to the pharmacy to get it signed. How would you be able to get that through the mail? The same, you know, for refills. (Non-user) KPHI, 5.
I didn’t even know that you [could] call and [order] over the phone…(User) KPHI, 2.
Not everybody is computer literacy, you know. So, like, at my house, we have a computer, but I will say, “Hon, can you do this for me? Hon, can you do that for me?” But it’s where – if I go on a computer and I look for prescriptions, I wouldn’t know which one to press. (Non-user) KPHI, 8.
Mail order pharmacy use is associated with better medication adherence and health care outcomes in diabetes patients, but little is known about patients’ barriers and facilitators to mail order use. Our focus groups and qualitative analysis showed that some diabetes patients may encounter important barriers to leveraging the opportunity to use mail order pharmacy, including difficulties using the ordering system, order accuracy, concerns about mail box security, longer waiting times for receiving medication compared to in-person refills, and concerns that insulin delivery via mail would compromise the safety and efficacy of the medication. One survey study of patients between the ages of 65 and 79 found that seniors’ concerns about mail order pharmacy use included the potential for lost or stolen medications, receiving the correct medication, and concerns that outdoor exposure may harm the prescription medication’s efficacy . Our study uncovered similar concerns, and contributes to the evidence based with the new additional finding that these concerns may apply to diabetes-specific medications such as insulin. Another study that interviewed veterans living with AIDS/HIV found patients were concerned their medications might run out before a new prescription fill arrived in the mail; this finding was echoed in our analysis as well. Still, prior studies suggest that mail order pharmacy users are more satisfied with pharmacy services than traditional community ‘brick and mortar’ pharmacy users [37,38,39]; addressing the barriers to mail order pharmacy use thus has the potential to increase satisfaction while improving health care outcomes and reducing costs. Health care systems and pharmacy benefit managers should address these issues to improve the patient experience and encourage mail order pharmacy use in those patients who could benefit from the service.
Patients in our study cited numerous facilitators that encouraged opportunities to use the mail order pharmacy, including not having to wait in line in-person or having to travel to the pharmacy to refill their medications. Patients whose benefits included a mail order pharmacy incentive to receive an extra copayment’s worth of medication day’s supply for free when paying for two copayment’s worth (e.g. three for the price of two) and using mail order saw this as a facilitator as well. Since 90–100 day fills of diabetes medication are standard in these settings, most diabetes patients eligible for this incentive could likely benefit. This finding is consistent with that of a prior focus group study focused on understanding drug benefit decisions among adults ages 65 and older, which found that access to mail order pharmacy services was a valued attribute in prescription drug plans . Promoting these attributes that can encourage patients to consistently use mail order pharmacy services, and expanding the drug benefit that allows for greater days’ supply for similar cost when using mail order, may be approaches to increase the uptake of prescription home delivery .
It is important to note that patients had a variety of perspectives on mail order pharmacy and themes occasionally contradicted one another. For example, some patients felt the mail order pharmacy system was unreliable and the delivery date unpredictable, whereas others felt the system was reliable and cited delivery notifications as facilitating its use. In another example, the need for in-person interactions with pharmacists and staff was cited as both a barrier and facilitator to mail order pharmacy use. Patients’ experience and understanding of mail order pharmacy services will not be universal, and health care systems should target outreach and communication to those who may be more in need of information. In addition, mail order pharmacy services should continue to offer the opportunity for one-on-one consultations with pharmacists to address medication questions and concerns, and allow patients to fill prescriptions at brick-and-mortar pharmacies in person if that is their personal preference .
This study has limitations that should be noted. The focus group format and structure did not allow for understanding differences in results by patient characteristics such as age, gender, or socioeconomic status; prior studies suggest preference for mail order pharmacy vs. community pharmacy may vary by some of these characteristics [17, 42]. However, a strength of our study was the diversity of the participants who participated in the focus groups; a majority were non-Hispanic White. Social desirability bias in pharmacy services research  may have led patients to underemphasize the barriers to mail order pharmacy use within their health care system. However, the number of barriers uncovered as well as the consistency with prior research lends validity to these results. This study defined non-users of mail order pharmacy as those who had not used mail order for refills within the past 12 months; it is possible that “non-users” could have had experience with mail order pharmacy in the more distant past.
This study focused on diabetes patients; patients with other conditions may have different experiences with mail order pharmacy. However, other studies of mail order pharmacy use in patients with different chronic conditions have found similar themes. This study took place in two integrated delivery systems within the United States. Results might not be fully generalizable to other health care delivery systems, and the organizational roles and responsibilities for improving mail order pharmacy services may be different in other settings, particularly those that are less integrated or that don’t operate their own pharmacy services. Finally, we are unable to compare the effectiveness of the mail order pharmacy services examined in this study to those in other settings or countries, as these data are unavailable.
Our study found that while patients with diabetes may benefit from mail order pharmacy use, they perceive numerous barriers and facilitators to using the service. These findings derived through this qualitative work, can be used to design interventions and quality improvement initiatives to increase mail order pharmacy use and promote improved medication adherence and outcomes in diabetes patients, across health care systems.
Availability of data and materials
The qualitative datasets analysed during the current study are not publicly available since consent for sharing data was not granted by participants; de-identified data may be available from the corresponding author on reasonable request.
Capability, opportunity, motivation, and behavior
Institutional review board
Kaiser Permanente Hawaii
Kaiser Permanente Northern California
- SGL2 inhibitor:
Theoretical domains framework
Centers for Disease Control and Prevention (CDC) About Diabetes. https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed 10 Dec 2018.
American Diabetes Association (ADA). Statistics about diabetes. http://diabetes.org/diabetes-basics/statistics/. Accessed 11 Feb 2019.
Centers for Disease Control and Prevention (CDC). Increasing prevalence of diagnosed diabetes--United States and Puerto Rico, 1995-2010. MMWR Morb Mortal Wkly Rep. 2012;61(45):918–21.
Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.
Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149–53.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.
DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.
Feldman R, Bacher M, Campbell N, Drover A, Chockalingam A. Adherence to pharmacologic management of hypertension. Can J Public Health. 1998;89(5):I16–8.
Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA. 1998;279(18):1458–62.
Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853–60 PubMed PMID: 17893306.
Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, Piette JD, Ross-Degnan D. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24. https://doi.org/10.1186/1472-6963-9-24 PubMed PMID: 19200387; PubMed Central PMCID: PMC2645384.
Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc. 2006;98(7):1071–7 PubMed PMID: 16895275; PubMed Central PMCID:PMC2569450.
Tseng CW, Tierney EF, Gerzoff RB, Dudley RA, Waitzfelder B, Ackermann RT, Karter AJ, Piette J, Crosson JC, Ngo-Metzger Q, Chung R, Mangione CM. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the translating research into action for diabetes study. Diabetes Care. 2008;31(2):261–6 Epub 2007 Nov 13. PubMed PMID: 18000177.
Peeters B, Van Tongelen I, Boussery K, Mehuys E, Remon JP, Willems S. Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from type 2 diabetes: a systematic literature review and suggestions for further research. Diabet Med. 2011;28(3):262–75. https://doi.org/10.1111/j.1464-5491.2010.03133.x Review. PubMed PMID: 21309834.
Duru OK, Gerzoff RB, Selby JV, Brown AF, Ackermann RT, Karter AJ, Ross S, Steers N, Herman WH, Waitzfelder B, Mangione CM. Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study. Med Care. 2009;47(6):700–6 PubMed PMID: 19480090; PubMed Central PMCID: PMC2743318.
Rupp MT. Attitudes of Medicare-eligible Americans towards mail service pharmacy. J Manag Care Pharm. 2013;19(7):564–72.
Duru OK, Schmittdiel J, Dyer W, Parker M, Uratsu C, Chan J, Karter A. Mail order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010;15(1):33–40 PMCID: PMC3015238.
Schmittdiel J, Karter A, Dyer W, Parker M, Uratsu C, Chan J, Duru OK. The comparative effectiveness of mail order pharmacy vs. local pharmacy use on LDL-C control in new statin users. J Gen Intern Med. 2011;12:1396–402 PMCID: PMC3235607.
Sharma KP, Taylor TN. Pharmacy effect on adherence to antidiabetic medications. Med Care. 2012;50:685–91.
Zhang L, Zakharyan A, Stockl KM, Harada ASM, Curtis BS, Solow BK. Mail-order pharmacy use and medication adherence among Medicare part D beneficiaries with diabetes. J Med Econ. 2011;14(5):562–7.
Devine S, Vlahiotis A, Sundar H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ. 2010;13(2):203–2011.
Fernandez E, McDaniel JA, Carroll NV. Examination of the link between medication adherence and use of mail-order pharmacies in chronic disease status. J Manag Care Spec Pharm. 2016;22(11):1247–59.
Neil WP, Shiokari CE, Burchette RJ, Stapleton D, Ovbiagele B. Mail order pharmacy use and adherence to secondary prevention drugs among stroke patients. J Neurol Sci. 2018;390:117–20.
Kim J, Hartzema AG. Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome. Sleep Med. 2018;44:45–52.
Adams AS, Uratsu C, Dyer W, Magid D, O’Connor P, Beck A, Butler M, Ho M, Schmittdiel J. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013;173(1):54–61.
Linton A, Bacon T, Peterson M. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary. J Manag Care Pharm. 2019;15(1):42–54.
Ma J, Wang L. Characteristics of mail-order pharmacy users: results from the medical expenditures panel survey. J Pharm Pract. 2018; oct 2:897190018800188 [epub ahead of print].
Clark BE, Siracuse MV. Garis RI. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans. Res Social Adm Pharm. 2009;5(2):133–42.
Tan X, Feng X, Chang J, Higa G, Wang L, Leslie D. Oral antidiabetic drug use and associated health outcomes in cancer patients. J Clin Pharm Ther. 2016;41:524–31.
Patton MQ. Qualitative research and evaluation. 3rd ed. Thousand Oaks: Sage Publications Inc; 2002.
Kiernan M, Kiernan NE, Goldberg J. Using standard phrases in qualitative interviews. Tipsheet #69. University Park, PA: Penn State cooperative extension; 2003.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101 PMID.
Strauss A, Corbin JM. Basics of qualitative research: Grounded theory procedures and techniques. Thousand oaks: US: sage publications, Inc; 1990.
Michie S, Atkins L, West R. The behaviour change wheel: a guide to designing interventions. London: Silverback Publishing; 2014.
Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care. 2005;14(1):26–33 PMID. 15692000.
Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implement Sci. 2012;7:37 PMID. 22530986.
Johnson JA, Coons SJ, Hays RD, Sabers D, Jones P, Langley PC. A comparison of satisfaction with mail versus traditional pharmacy services. J Manag Care Pharm. 1997;3:327–37.
Motheral BR, Heinle SM. Predictors of satisfaction with health plan members with prescription drug benefits. Am J Health-Syst Phar. 2004;19:1007–14.
Desai KR, Chewning B, Wilcox A, Safdar N. Mail-order pharmacy experience of veterans living with AIDS/HIV. Res Soc Adm Pharm. 2018;14:153–61.
Cline RR, Gupta K. Drug benefit decisions among older adults: a policy-capturing analysis. Medical Decision Making/May–June 2006 (273–281).
Karter AJ, Parker MM, Duru KO, Schillinger D, Adler N, Moffet HH, Adams AS, Chan J, Herman W, Schmittdiel JA. Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the diabetes study of northern California (DISTANCE). Health Serv Res. 2015;50(2):537–59.
Liberman JN, Wang Y, Hutchins DS, Slezak J, Shrank WH. Revealed preference for community and mail service pharmacy. J Am Pharm Assoc (2003). 2011;51(1):50–7.
Kimberlin CL, Winterstein AG. Validity and reliability of measurement instruments used in research. Am J Health Syst Pharm. 2008;65:2276–84.
This study was funded by NIDDK grant number 1R18DK104249-01A1. Drs. Schmittdiel, Karter, and Wharam also received support from the Health Delivery Systems Center for Diabetes Translational Research (P30 DK092924).
Ethics approval and consent to participate
This study was approved by the Kaiser Permanente Northern California Institutional Review Board; Kaiser Permanente Hawaii’s IRB ceded oversight for this study. Participants provided written informed consent to participate.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Schmittdiel, J.A., Marshall, C.J., Wiley, D. et al. Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study. BMC Health Serv Res 19, 422 (2019) doi:10.1186/s12913-019-4250-7
- Mail order pharmacy
- Barriers and facilitators
- Patient preference
- Acceptance of health care
- Qualitative research